Abstract
purpose. Several studies have investigated the changes in retinal vessel diameter during physiological stress or pathologic conditions. These studies were principally based on individual fundus photographs and as such did not allow the evaluation of vessel dynamics over time. The research objective was to detail the time course and amplitude changes in the diameter of arteries and veins across all retinal quadrants, during and after hyperoxic vascular stress.
methods. The dynamics of changes in retinal vessel diameter were quantified with a retinal vessel analyzer, which digitizes fundus images in real time and simultaneously quantifies vessel diameter. The arterial and venous diameters within one disc diameter of the optic nerve head in each quadrant were studied. Twenty young adults participated in this study in which the vessel diameters were measured during successive phases of breathing either room air or pure oxygen. The oxygen saturation level (SaO2), end-tidal carbon dioxide (EtCO2), pulse rate (PR), respiratory rate (RR), and blood pressure (BP) were also monitored throughout testing.
results. Breathing 100% O2 caused an increase in SaO2 and a decrease in the EtCO2. All other systemic parameters measured (PR, RR, BP, and ocular perfusion pressure [OPP]) remained unchanged. However, the retinal veins and arteries constricted by ∼14% and ∼9% respectively, in all retinal quadrants. After experimental hyperoxia, inhalation of room air was associated with a progressive increase in the caliber of vessels toward their pretest size. The amplitude and overall profile of vessel reactivity to and recovery from hyperoxia was the same across retinal quadrants.
conclusions. These data indicate that, during systemic hyperoxic stress, the retinal vessels change in caliber uniformly across retinal quadrants in healthy young adults. This type of physiological vascular provocation could be used to investigate the quality of vascular regulation during aging and in vascular diseases of the eye.
The retinal vasculature does not have sympathetic innervation
1 ; rather, it maintains optimal nutrition and oxygenation of the retina through vascular autoregulation. Autoregulation is the ability to keep blood flow constant despite altered perfusion pressure, or to adjust blood flow to the metabolic requirements of a given tissue.
2 These mechanisms are mediated, for example, by factors such as the pH level, various endothelial vasoactive agents (endothelin, nitric oxide), or oxygen and carbon dioxide tension.
3
Ocular hemodynamic responses and retinal vessel reactivity have been studied by using various noninvasive procedures such as aerobic exercise,
4 5 altered body position,
6 cold pressor stimulation,
7 or blood gas perturbations.
8 9
Provocation through breathing pure oxygen has been used to demonstrate retinal vascular autoregulation,
10 11 12 13 seen as a vasoconstriction of retinal vessels
10 14 15 16 or a decrease in retinal blood flow.
15 16 Pure oxygen breathing has also been used to reveal abnormal autoregulation in ocular diseases such as diabetic retinopathy
17 or glaucoma.
18 Other studies have used pure oxygen breathing and reported either regional retinal differences in vascular reactivity,
13 19 or no regional differences.
20
The investigation of retinal vascular reactivity in the various regions of the retina is particularly important in view of reports indicating that some vascular ocular diseases may affect a portion of the retina and/or visual field to a larger degree. In glaucoma, it has been reported that the superior visual field was affected more often than the inferior visual field
21 and that retinal vessel narrowing with progression of disease was more pronounced in the inferior retina.
22 In diabetes, vascular anomalies have been reported to be more frequent in the superior retina,
23 24 although it has also been shown that decreased visual field sensitivity tends to be localized in the superior quadrants.
25
To our knowledge, in only one study has the human retinal vessel reactivity to systemic hyperoxia in all retinal quadrants been investigated.
13 The authors used a retinal vessel analyzer (RVA)
26 27 to study the effect of prolonged hyperoxia on the time course of retinal vasoconstriction. They reported a greater vessel reactivity to oxygen in the temporal than in the nasal arteries and veins. Unfortunately, no data were presented for the individual quadrants or the superior versus inferior retina. Furthermore, no attempt was made to evaluate the time course for recovery from the vascular stress.
Our specific objective was to detail the time course and magnitude of changes in the diameter of arteries and veins across all retinal quadrants, before, during, and after hyperoxic vascular stress.
A continuously recording, noninvasive BP system (NIBP 7000; Colin, San Antonio, TX) was used to monitor systemic BP throughout the experiment. A piezoelectric sensor placed over the radial artery was calibrated to yield BPs identical with those of the brachial artery. The NIBP output was processed on computer (Acknowledge software; BioPac, Santa-Barbara, CA) which provided real-time (25 Hz) measurements of the systolic and diastolic BP and the quantification of the BPmean and ocular perfusion pressure (OPP). The OPP was derived online from the BPmean data and the IOP that had been entered into the analysis program for each subject. The following formulas were used for deriving the BPmean and the OPP: BPmean = BPdiast + (BPsyst − BPdiast)/3 and OPP = \({2}/{3}\) BPmean − IOP.
A soft rubber mask (7930 series; Hans-Rudolph, Kansas City, MO) was placed over the subject’s mouth and nose, with the nares clipped closed, to ensure that breathing would be through the mouth only. The subject was then positioned at the fundus camera component of the RVA system. Two one-way valves allowed the test gas to be inhaled on one side and exhaled on the other side of the mask. The exhaled air was fed into a capnograph/oximeter system (model 7100 CO2SMO, Novametrix; Trudell Medical, Montréal, Québec, Canada) for quantification of the end-tidal carbon dioxide (EtCO2) and respiratory rate (RR). An infrared sensor attached to the CO2SMO system was clipped to the middle finger of the left hand for oxygen saturation (SaO2) and PR measurements. The EtCO2, RR, SaO2, and PR were monitored continuously throughout the experiment.
All testing was performed in a quiet, dimly illuminated laboratory, at normal room temperature and at sea level atmospheric pressure. The test protocol was divided into three consecutive phases in which the subject had to inhale: (1) room air for 2 minutes, (2) 100% oxygen for 12 minutes, and (3) room air for 12 minutes, through the air-tight face mask. These three phases were considered the baseline, pure oxygen-breathing, and recovery phases, respectively. At the end of baseline, the reservoir bag filled with oxygen was connected to the mask to start inhalation of pure oxygen, and this bag was quickly disconnected once the recovery phase began. Event markers were placed on each of the NIBP, CO2SMO, and RVA systems to indicate the beginning and the end of the three test phases.
Each data set for the SaO2, EtCO2, PR, RR, BPmean, BPsyst, BPdiast, and OPP was group averaged across subjects, as a function of time into the experiment, to generate population trends in data over time. To quantify subject responses to each physiological variable, all data for each experimental phase were group averaged. However, for the SaO2 and EtCO2, only the most steady segments during breathing of pure oxygen were averaged for that particular experimental phase.
For each subject and vessel, the data were normalized to a common baseline level by assigning 100% to the mean value averaged over the 2-minute baseline interval. All normalized data were then group averaged across subjects for each artery and vein measured in each retinal quadrant to evaluate changes over time. The nine separate variables measured for vessel responses throughout the experiment are identified schematically in
Figure 2 . Data analyses included the following: (1) average of all baseline recordings, (2) time before vasoconstriction response to oxygen, (3) rate of the vasoconstriction, (4) latency before the plateau in vasoconstriction, (5) average of all vessel measurements in the vasoconstriction plateau contained in the pure oxygen phase, (6) time for the onset of recovery from vasoconstriction, (7) rate of the recovery from vasoconstriction, (8) latency before the plateau in recovery, and (9) average of all vessel caliber values in the recovery plateau. These parameters were group averaged across all subjects to reveal the population response to the physiological provocation of breathing pure oxygen.
Systemic hyperoxia was achieved during breathing of 100% oxygen, as indicated by the increased SaO
2 level. Because our experimental design did not require an isocapnic stimulus,
28 systemic hyperoxia was accompanied by a decrease in EtCO
2, which probably represents the reduced affinity of hemoglobin for CO
2 known to occur when the oxygen partial pressure is increased.
29 Both the SaO
2 and EtCO
2 quickly resumed their baseline values after discontinuation of pure oxygen breathing. The change in EtCO
2 was not accompanied by a change in the RR. Also, there were no alterations in the group-averaged PR during systemic hyperoxia.
In the present study, the BP measurements were acquired at 25 Hz throughout testing. Lovasik et al.
5 were the first to use this NIBP technology to reveal the presence of choroidal blood flow regulation, showing a 43% increase in OPP without a parallel alteration in the choroidal blood flow. To our knowledge, no study has detailed the time course of OPP while breathing pure oxygen. Our present results revealed that the systemic BP and the OPP remained relatively constant throughout transient experimental hyperoxia. The IOP was measured only before testing because an earlier study had shown that pure oxygen breathing reduced the IOP by only 1 mm Hg, a change that would not have modified the OPP significantly.
8 Furthermore, it has recently been reported that although the IOP decreases during systemic hyperoxia, it does not alter significantly the level of OPP.
30
Earlier studies have reported that retinal blood flow is higher in the temporal versus nasal retina but is the same in the superior versus inferior retina.
20 31 32 Although blood flow was not measured in the present study, our results indicated that the baseline vessel diameters were larger in the temporal than in the nasal retina, but similar between the superior and inferior retina. This was the case for the comparisons of vessels across retinal quadrants, as well as of the temporal versus nasal or superior versus inferior hemiretinas. Our data therefore are in agreement with earlier blood flow studies, considering that blood flow is a function of the fourth power of the radius of a vessel
33 (i.e., very small changes in vessel diameter are needed to cause large changes in blood flow). These regional differences in retinal blood flow have been attributed to the fact that the temporal retina is larger than its nasal counterpart and contains the highly metabolic macular area.
34 35
Our results show that systemic hyperoxia induces a vasoconstriction in the arteries and veins in each of the four retinal quadrants. On average, the veins constricted by 14.5% and the arteries by 9.2%. These results compare well with those in other studies that involved the use of pure oxygen to investigate vessel reactivity. In these studies, investigators recorded a 14.9% decrease in retinal vein diameter,
36 a 12% reduction in artery and vein diameter,
10 and a 13% to 15% and 11% to 12% reduction in retinal vein and artery diameters, respectively,
13 with systemic hyperoxia.
The degree of hyperoxia-induced vasoconstriction was found not to differ between veins across retinal quadrants, nor did it differ between arteries across quadrants. An additional analysis, looking at the temporal versus nasal retina and superior versus inferior retina also indicated that there were no regional differences in the degree of hyperoxia-induced arterial and venous constriction across retinal sectors. Our results differ from those published recently by Kiss et al.,
13 who also used the RVA system to investigate the vessel reactivity to an oxygen-induced vascular stress. They reported that the retinal vasoconstriction achieved by the nasal arteries and veins was less pronounced than that of the temporal vessels. Our data are more in line with those presented earlier by Rassam et al.
20 who quantified vessel changes from standard photographs of the ocular fundus. Even though this approach produced limited measurements, their observation that systemic hyperoxia induces a similar degree of constriction in temporal and nasal vessels is in agreement with our present findings. Our data further showed that there were no differences in the level of vasoconstriction across retinal quadrants or between the superior versus inferior retina. Overall, the present study indicated that in young healthy adults, there was no differential reactivity across the retina to a short-lived but potent metabolic vascular stress.
Because all vessel measurements in this study were made within 1 DD of the ONH border, small-caliber changes in these principal vessels would cause significant blood flow changes upstream in smaller vessels. Additional studies will be undertaken to measure the caliber changes in vessels at different distances from the ONH. Focal differences in vessel reactivity to changes in arterial oxygen saturation may help explain differences in vessel reactivity reported in different studies.
In this study, we recruited a similar number of men and women as subjects. Although we are not aware of any study showing that the retinal vessel reactivity is different in men and women, some reports have discussed gender-related differences in ocular blood flow. A few studies have reported that women have a higher pulsatile ocular blood flow than do men.
37 38 39 On the contrary, it has been reported that the subfoveal choroidal blood flow
40 ; the blood flow and vascular resistance in the ophthalmic artery
41 ; and the blood flow velocity in the ophthalmic artery, central retinal artery, central retinal vein, and short posterior ciliary arteries
42 are not different between men and women. Our present study revealed a uniform vasoconstriction across quadrants in both men and women that is consistent with autoregulatory responses to transient hyperoxia.
Our study showed that the rate of vasoconstriction in both arteries and veins was greater than the rate of recovery from vasoconstriction. This suggests that vasoconstriction is the result of positive innervation, whereas the recovery from vasoconstriction after oxygen inhalation is a more passive phenomenon. This interpretation is consistent with the observation that the time needed to achieve maximum vessel constriction was shorter than the time taken to recover from this level of vasoconstriction. The short delay before the initiation of retinal vasoconstriction and recovery from vasoconstriction closely matched the time course of experimentally induced systemic hyperoxia. The time-response dynamics of the arteries and veins was similar across retinal quadrants. Our measurements indicated that it took about 3 to 4 minutes for retinal vasoconstriction to develop fully in response to systemic hyperoxia, a finding that is in line with other published data.
13 Finally, our results also revealed that the recovery from vasoconstriction occurred over a minimum of 4 minutes, but typically followed a longer time course for a return toward baseline.
This first ever characterization of retinal vessel reactivity and recovery from transient systemic hyperoxia revealed uniform changes in the caliber of both the arteries and veins projecting into the four principal quadrants of the fundus. Such innocuous physiological provocation may be useful clinically for evaluating the functional integrity of retinal vascular autoregulation. Furthermore, the amplitude and timing of vasomotor responses may have diagnostic power for vascular disease of the human retina.
Supported by Natural Sciences and Engineering Research Council of Canada OGP0116910 (JVL) and OGP0121750 (HK), Canadian Foundation for Innovation (JVL, HK), Canadian Optometric Education Trust Fund (SJ-L, HK), Fonds de la Recherche en Santé du Québec (HK).
Submitted for publication October 13, 2004; revised December 14, 2004; accepted January 10, 2005.
Disclosure:
S. Jean-Louis, None;
J.V. Lovasik, None;
H. Kergoat, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked “
advertisement” in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Corresponding author: Hélène Kergoat, Université de Montréal, École d’optométrie, C.P. 6128, Succursale Centre-Ville, Montréal, Québec H3C 3J7, Canada;
[email protected].
Table 1. Group-Averaged Results for the Physiological Variables Obtained throughout the Experiment
Table 1. Group-Averaged Results for the Physiological Variables Obtained throughout the Experiment
Physiological Variables | Baseline (Air-21% O2) | Hyperoxia (100% O2) | Recovery (Air-21% O2) |
SaO2 (%) | 97.4 ± 0.21 | 98.7 ± 0.15* | 97.6 ± 0.20 |
EtCO2 (mm Hg) | 39.5 ± 0.94 | 35.7 ± 1.10* | 38.5 ± 0.76 |
PR (bpm) | 73.2 ± 2.75 | 71.5 ± 2.62 | 74.0 ± 2.62 |
RR (breaths/min) | 14.7 ± 0.90 | 13.9 ± 0.96 | 14.3 ± 1.02 |
BPsyst (mm Hg) | 120.0 ± 2.93 | 120.8 ± 3.52 | 122.5 ± 3.19 |
BPdiast (mm Hg) | 63.2 ± 2.19 | 63.6 ± 2.17 | 62.8 ± 2.64 |
BPmean (mm Hg) | 83.7 ± 1.90 | 83.9 ± 2.33 | 84.3 ± 2.40 |
OPP (mm Hg) | 40.6 ± 1.29 | 40.1 ± 1.58 | 40.1 ± 1.71 |
Table 2. Summary Statistics Comparing the Baseline Vessel Diameters
Table 2. Summary Statistics Comparing the Baseline Vessel Diameters
Retinal Region | Vessel Diameter (AU) | P |
IN arteries | 109.0 ± 3.6 | NS* |
SN arteries | 105.86 ± 3.2 | |
IT arteries | 124.72 ± 4.5 | NS |
ST arteries | 120.73 ± 3.3 | |
IN arteries | 109.0 ± 3.6 | NS |
IT arteries | 124.72 ± 4.5 | |
SN arteries | 105.86 ± 3.2 | 0.0004 |
ST arteries | 120.73 ± 3.3 | |
IN veins | 110.95 ± 2.4 | NS |
SN veins | 115.18 ± 3.8 | |
IT veins | 141.7 ± 5.9 | NS |
ST veins | 142.7 ± 4.6 | |
IN veins | 110.95 ± 2.4 | 0.0008 |
IT veins | 141.7 ± 5.9 | |
SN veins | 115.18 ± 3.8 | 0.0001 |
ST veins | 142.7 ± 4.6 | |
I arteries | 116.65 ± 3.1 | NS |
S arteries | 113.48 ± 2.5 | |
I veins | 126.91 ± 4.0 | NS |
S veins | 129.30 ± 3.7 | |
N arteries | 107.33 ± 2.2 | <0.0001 |
T arteries | 122.44 ± 2.7 | |
N veins | 113.13 ± 2.3 | <0.0001 |
T veins | 141.99 ± 3.6 | |
The authors thank all subjects for their participation in this demanding experiment and Marc Melillo, Normand Lalonde, Micheline Gloin, Denis Latendresse, and André Mathieu for expert computer and technical help.
AlmA, BillA. Ocular circulation.MosesRA HartWM, Jr eds. Alder’s Physiology of the Eye. 1987; 8th ed. 183–203.
GuytonAC, RossJM, CarrierO, WalkerJR. Evidence for tissue oxygen demand as the major factor causing autoregulation. Circ Res. 1954;1(suppl 14/15)60–69.
BillA, SperberGO. Control of retinal and choroidal blood flow. Eye. 1990;4:319–325.
[CrossRef] [PubMed]KergoatH, LovasikJV. Response of parapapillary retinal vessels to exercise. Optom Vis Sci. 1995;72:249–257.
[CrossRef] [PubMed]LovasikJV, KergoatH, RivaCE, PetrigBL, GeiserM. Choroidal blood flow during exercise-induced changes in the ocular perfusion pressure. Invest Ophthalmol Vis Sci. 2003;44:2126–2132.
[CrossRef] [PubMed]LovasikJV, KergoatH. Gravity-induced homeostatic reactions in the macular and choroidal vasculature of the human eye. Aviat Space Environ Med. 1994;65:1010–1014.
[PubMed]RojanapongpunP, DranceSM. The response of blood flow velocity in the ophthalmic artery and blood flow of the finger to warm and cold stimuli in glaucomatous patients. Graefes Arch Clin Exp Ophthalmol. 1993;231:375–377.
[CrossRef] [PubMed]KergoatH, FaucherC. Effects of oxygen and carbogen breathing on choroidal hemodynamics in humans. Invest Ophthalmol Vis Sci. 1999;470:2906–2911.
GeiserMH, RivaCE, DornerGT, DiermannU, LukschA, SchmettererL. Response of choroidal blood flow in the foveal region to hyperoxia and hyperoxia-hypercapnia. Curr Eye Res. 2000;21:669–676.
[CrossRef] [PubMed]RivaCE, GrunwaldJE, SinclairSH. Laser Doppler velocimetry study of the effect of pure oxygen breathing on retinal blood flow. Invest Ophthalmol Vis Sci. 1983;24:47–51.
[PubMed]HagueS, HillDW, CrabtreeA. The calibre changes of retinal vessels subject to prolonged hyperoxia. Exp Eye Res. 1988;47:87–96.
[CrossRef] [PubMed]LanghansM, MichelsonG, GrohMJ. Effect of breathing 100% oxygen on retinal and optic nerve head capillary blood flow in smokers and non-smokers. Br J Ophthalmol. 1997;81:365–369.
[CrossRef] [PubMed]KissB, PolskaE, DornerG, et al. Retinal blood flow during hyperoxia in human revisited: concerted results using different measurement techniques. Microvasc Res. 2002;64:75–85.
[CrossRef] [PubMed]DeutschTA, ReadJS, ErnestJT, GoldstickTK. Effects of oxygen and carbon dioxide on the retinal vasculature in human. Arch Ophthalmol. 1983;101:1278–1280.
[CrossRef] [PubMed]FallonTJ, MaxwellD, KohnerEM. Retinal vascular autoregulation in conditions of hyperoxia and hypoxia using the blue field entoptic phenomenon. Ophthalmology. 1985;92:701–705.
[CrossRef] [PubMed]PakolaSJ, GrunwaldJE. Effects of oxygen and carbon dioxide on human retinal circulation. Invest Ophthalmol Vis Sci. 1993;34:2866–2870.
[PubMed]RassamSM, PatelV, KohnerEM. The effect of experimental hypertension on retinal vascular autoregulation in humans: a mechanism for the progression of diabetic retinopathy. Exp Physiol. 1995;80:53–68.
[CrossRef] [PubMed]GrunwaldJE, RivaCE, PetrigBL, SinclairSH, BruckerAJ. Effect of pure O2-breathing on retinal blood flow in normals and in patients with background diabetic retinopathy. Curr Eye Res. 1984;3:239–241.
[CrossRef] [PubMed]ChungHS, HarrisA, HalterPJ, et al. Regional differences in retinal vascular reactivity. Invest Ophthalmol Vis Sci. 1999;40:2448–2453.
[PubMed]RassamSMB, PatelV, ChenC, KohnerEM. Regional retinal blood flow and vascular autoregulation. Eye. 1996;10:331–337.
[CrossRef] [PubMed]HartWM, Jr, BeckerB. The onset and evolution of glaucomatous visual field defects. Ophthalmology. 1982;89:268–279.
[CrossRef] [PubMed]JonasJB, NguyenXN, NaumannGO. Parapapillary retinal vessel diameter in normal and glaucoma eyes. I. Morphometric data. Invest Ophthalmol Vis Sci. 1989;30:1599–1603.
[PubMed]FalckA, LaatikainenL. Retinal vasodilation and hyperglycaemia in diabetic children and adolescents. Acta Ophthalmol Scand. 1995;73:119–124.
[PubMed]KernTS, EngermanRL. Vascular lesions in diabetes are distributed non-uniformly within the retina. Exp Eye Res. 1995;60:545–549.
[CrossRef] [PubMed]TrickGL, TrickLR, KiloC. Visual field defects in patients with insulin-dependent and noninsulin-dependent diabetes. Ophthalmology. 1990;97:475–482.
[CrossRef] [PubMed]VilserW, NagelE, LanzlI. Retinal vessel analysis: new possibilities. Biomed Tech (Berl). 2002;47(suppl 1)682–685.
[CrossRef] [PubMed]SeifertlBU, VilserW. Retinal Vessel Analyzer (RVA): design and function. Biomed Tech (Berl). 2002;47(suppl 1)678–681.
[CrossRef] [PubMed]GilmoreED, HudsonC, VenkataramanST, PreissD, FisherJ. Comparison of different hyperoxic paradigms to induce vasoconstriction: implications for the investigation of retinal vascular reactivity. Invest Ophthalmol Vis Sci. 2004;45:3207–3212.
[CrossRef] [PubMed]NunnJF. Nunn’s Applied Respiratory Physiology. 1993; 4th ed.Butterworth-Heinemann Oxford, UK.
HoskingSL, HarrisA, ChungHS, et al. Ocular haemodynamic responses to induced hypercapnia and hyperoxia in glaucoma. Br J Ophthalmol. 2004;88:406–411.
[CrossRef] [PubMed]RivaCE, GrunwaldJE, SinclairSH, PetrigBL. Blood velocity and volumetric flow rate in human retinal vessels. Invest Ophthalmol Vis Sci. 1985;26:1124–1132.
[PubMed]FekeGT, TagawaH, DeupreeDM, GogerDG, SebagJ, WeiterJJ. Blood flow in the normal human retina. Invest Ophthalmol Vis Sci. 1989;30:58–65.
[PubMed]GuytonAC, HallJE. Textbook of Medical Physiology. 1996; 9th ed.WB Saunders Philadelphia.
AlmA, BillA. Ocular and optic nerve blood flow at normal and increased intraocular pressures in monkeys (
Macaca irus): a study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Exp Eye Res. 1973;15:15–29.
[CrossRef] [PubMed]HillDW. The regional distribution of retinal circulation. Ann Coll Surg Eng. 1977;59:470–475.
HickamJB, FrayserR, RossJC. A study of retinal venous blood oxygen saturation in human subjects by photographic means. Circulation. 1963;27:375–385.
[CrossRef] [PubMed]GekkievaM, OrgulS, GherghelD, GugletaK, PrunteC, FlammerJ. The influence of sex difference in measurements with the Langham Ocular Blood Flow System. Jpn J Ophthalmol. 2001;45:528–532.
[CrossRef] [PubMed]AgarwalHC, GuptaV, SihotaR, SinghK. Pulsatile ocular blood flow among normal subjects and patients with high tension glaucoma. Indian J Ophthalmol. 2003;51:133–138.
[PubMed]GeyerO, SilverDM, MathalonN, MasseyAD. Gender and age effects on pulsatile ocular blood flow. Ophthalmic Res. 2003;35:247–250.
[CrossRef] [PubMed]StraubhaarM, OrgulS, GugletaK, SchotzauA, ErbC, FlammerJ. Choroidal laser Doppler flowmetry in healthy subjects. Arch Ophthalmol. 2000;118:211–215.
[CrossRef] [PubMed]GreenfieldDS, HeggerickPA, HedgesTR, III. Color Doppler imaging of normal orbital vasculature. Ophthalmology. 1995;102:1598–1605.
[CrossRef] [PubMed]KaiserHJ, SchotzauA, FlammerJ. Blood-flow velocities in the extraocular vessels in normal volunteers. Am J Ophthalmol. 1996;122:364–370.
[CrossRef] [PubMed]